Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Combined Hepatocellular Carcinoma and Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Fudan University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07105748	HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)(TASK-05)	recruiting	Phase 2	45	Fudan UniversityOTHER	1	Aug 17, 2025	clinicaltrials
NCT06541652	A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers(FFCD-2205)	recruiting	—	150	Federation Francophone de Cancerologie DigestiveOTHER